CIK: 1387521 - Address: C/O Sangamo Therapeutics, Inc., 501 Canal Blvd., Richmond, CA 94084
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1120-1332256
S%wins10010050500050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/18/18 18:31
1/16/18
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagMeyers James RCAOEVP WorlS.d-8,02480.240-100-973D
9/5/17 17:31
8/31/17
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagMeyers James RCAOEVP WorlS.d-4,99183.190-60-963D
4/26/07 13:25
4/24/07
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagMeyers James RCAOSVP CommS.d-74983.1833-9-901D113332231218620-1-2-10221
3/1/07 20:34
2/28/07
GILDGilead Sciences IncDEHealthBioPrdBiological Products, (No DiagMeyers James RCAOSVP CommS.d-42871.3533-6-851D101121388-1-1-30-1816128

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact